Pmv Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -32 | |||
EBITDA | -21,173 | -21,564 | -25,129 | -21,517 |
EBIT | -21,205 | -21,601 | -25,168 | -21,888 |
Net Income | -21,210 | -17,436 | -23,000 | -19,226 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,313 | -18,270 | -16,717 | -16,840 |
Cash | 44,127 | 51,341 | 40,876 | 48,810 |
Basic Shares | 52,010 | 51,952 | 51,574 | 51,574 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,257 | -650 | -1,281 | |
EBITDA | -73,665 | -78,875 | -76,725 | -57,986 |
EBIT | -74,809 | -80,132 | -77,040 | -58,293 |
Net Income | -58,709 | -68,960 | -73,317 | -57,846 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,170 | -188,133 | ||
Free Cash Flow | -51,937 | -56,619 | -71,744 | -47,920 |
Cash | 40,876 | 37,706 | 108,297 | 172,467 |
Basic Shares | 51,579 | 48,014 | 45,594 | 45,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.34 |
2024-12-31 | -$0.45 |
